IBANDRONATE REGIMEN FOR TREATING METASTATIC BONE PAIN

摘要

Disclosed is an improved dosing regimen for treating pain associated with metastatic bone disease comprising the quick administration of an IV loading dose of ibandronate followed by an oral or intravenous (IV) maintenance dosing regimen. This regimen provides desirable therapeutic effects, including fast onset of pain relief, with a tolerable level of toxicity and is preferable for patient compliance.